Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Ullmann

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Drug Discovery Today|January 28, 2003
Leveraging process integration in early drug discoveryNicolas Fay, Dirk Ullmann
Methods in Enzymology|March 5, 2011
HTS reporter displacement assay for fragment screening and fragment evolution toward leads with optimized binding kinetics, binding selectivity, and thermodynamic signatureLars Neumann, Konstanze von König, Dirk Ullmann
Bioorganic & Medicinal Chemistry Letters|December 15, 2015
Thermodynamic profiling of inhibitors of Nrf2:Keap1 interactionsHamid R Nasiri, Sandra Linge, Dirk Ullmann
Journal of Biomolecular Screening|June 6, 2006
Early identification of false positives in high-throughput screening for activators of p53-DNA interactionJulian Wölcke, Nicholas Hunt, Joern Jungmann, et al.
Drug Discovery Today|July 18, 2003
Highly sensitive fluorescence detection technology currently available for HTSChristian Eggeling, Leif Brand, Dirk Ullmann, et al.
Expert Opinion on Drug Discovery|March 19, 2013
Fragment screening by biochemical assayJohn Barker, Steve Courtney, Thomas Hesterkamp, et al.
Medchemcomm|August 16, 2018
PAIN-less identification and evaluation of small molecule inhibitors against protein tyrosine phosphatase 1BHamid R Nasiri, Philipp Mracek, Steffen K Grimm, et al.
Journal of Molecular Biology|January 16, 2003
Reconstructing the binding site of factor Xa in trypsin reveals ligand-induced structural plasticitySabine Reyda, Christian Sohn, Gerhard Klebe, et al.
Combinatorial Chemistry & High Throughput Screening|June 18, 2009
Novel MK2 inhibitors by fragment screeningOliver Keminer, Joachim Kraemer, Jan Kahmann, et al.
Plos One|March 22, 2013
The E. coli effector protein NleF is a caspase inhibitorSonja Blasche, Mario Mörtl, Holger Steuber, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Drug Discovery Today|January 28, 2003
Leveraging process integration in early drug discoveryNicolas Fay, Dirk Ullmann
Methods in Enzymology|March 5, 2011
HTS reporter displacement assay for fragment screening and fragment evolution toward leads with optimized binding kinetics, binding selectivity, and thermodynamic signatureLars Neumann, Konstanze von König, Dirk Ullmann
Bioorganic & Medicinal Chemistry Letters|December 15, 2015
Thermodynamic profiling of inhibitors of Nrf2:Keap1 interactionsHamid R Nasiri, Sandra Linge, Dirk Ullmann
Journal of Biomolecular Screening|June 6, 2006
Early identification of false positives in high-throughput screening for activators of p53-DNA interactionJulian Wölcke, Nicholas Hunt, Joern Jungmann, et al.
Drug Discovery Today|July 18, 2003
Highly sensitive fluorescence detection technology currently available for HTSChristian Eggeling, Leif Brand, Dirk Ullmann, et al.
Expert Opinion on Drug Discovery|March 19, 2013
Fragment screening by biochemical assayJohn Barker, Steve Courtney, Thomas Hesterkamp, et al.
Medchemcomm|August 16, 2018
PAIN-less identification and evaluation of small molecule inhibitors against protein tyrosine phosphatase 1BHamid R Nasiri, Philipp Mracek, Steffen K Grimm, et al.
Journal of Molecular Biology|January 16, 2003
Reconstructing the binding site of factor Xa in trypsin reveals ligand-induced structural plasticitySabine Reyda, Christian Sohn, Gerhard Klebe, et al.
Combinatorial Chemistry & High Throughput Screening|June 18, 2009
Novel MK2 inhibitors by fragment screeningOliver Keminer, Joachim Kraemer, Jan Kahmann, et al.
Plos One|March 22, 2013
The E. coli effector protein NleF is a caspase inhibitorSonja Blasche, Mario Mörtl, Holger Steuber, et al.
Pageof 1